76 related articles for article (PubMed ID: 2283973)
1. [Efficacy of intravenous ceftazidime in childhood infections].
Kanra G; Gürsavaş M; Aydin M; Cengizlier R; Seçmeer G; Ceyhan M
Mikrobiyol Bul; 1990 Jul; 24(3):226-36. PubMed ID: 2283973
[TBL] [Abstract][Full Text] [Related]
2. Evaluation of ceftazidime in the treatment of 80 infectious episodes in compromised children.
Viscoli C; Gargani G; Facco F; Mantero E; Tuo P; Giacchino R; Campelli A; Nantron M; Perlino G
Int J Clin Pharmacol Ther Toxicol; 1985 Nov; 23(11):629-34. PubMed ID: 3908333
[TBL] [Abstract][Full Text] [Related]
3. Randomized comparison of cefepime versus ceftazidime monotherapy for fever and neutropenia in children with solid tumors.
Kebudi R; Görgün O; Ayan I; Gürler N; Akici F; Töreci K
Med Pediatr Oncol; 2001 Apr; 36(4):434-41. PubMed ID: 11260566
[TBL] [Abstract][Full Text] [Related]
4. [Multicenter clinical study and pharmacokinetics of ceftazidime in children and newborn infants].
Bégué P; Michel B; Chasalette JP; Allouche G; Quinet B
Pathol Biol (Paris); 1986 May; 34(5):525-9. PubMed ID: 3534737
[TBL] [Abstract][Full Text] [Related]
5. [Treatment of febrile episodes in neutropenic children by ceftazidime combined with netilmicin. Results of a multicenter study apropos of 88 cases].
Leverger G; Demeocq F; Harousseau JL; Taboureau O; Vannier JP; Boilletot A; de Lumley L; Boutard P; Olive D; Reinert P
Pathol Biol (Paris); 1987 May; 35(5):648-51. PubMed ID: 3302878
[TBL] [Abstract][Full Text] [Related]
6. Local and general treatment with ceftazidime as monotherapy in central nervous system infections and in septicemic infection.
Fiori GP; Dietz A; Montanari M; Torre D
Int J Clin Pharmacol Ther Toxicol; 1985 Jun; 23(6):326-8. PubMed ID: 3894254
[TBL] [Abstract][Full Text] [Related]
7. Efficacy and tolerability of imipenem-cilastatin versus ceftazidime plus tobramycin as empiric therapy of presumed bacterial infection in neutropenic cancer patients.
Miller JA; Butler T; Beveridge RA; Kales AN; Binder RA; Smith LJ; Ueno WM; Milkovich G; Goldwater S; Marion A
Clin Ther; 1993; 15(3):486-99. PubMed ID: 8364941
[TBL] [Abstract][Full Text] [Related]
8. Empiric monotherapy in neutropenia: a realistic goal?
Del Favero A; Bucaneve G; Menichetti F
Scand J Infect Dis Suppl; 1995; 96():34-7. PubMed ID: 7652501
[TBL] [Abstract][Full Text] [Related]
9. A randomised dosage study of ceftazidime with single daily tobramycin for the empirical management of febrile neutropenia in patients with hematological diseases.
Gibson J; Johnson L; Snowdon L; Joshua D; Young G; MacLeod C; Iland H; Vincent P; Kronenberg H
Int J Hematol; 1994 Aug; 60(2):119-27. PubMed ID: 7948961
[TBL] [Abstract][Full Text] [Related]
10. Use of ceftazidime in febrile incidents in immunocompromised haematological patients.
d'Oliveira JJ; Pereira ME; Mateus LM; Monteiro JM; Parreira AS; Soares AD
J Int Med Res; 1986; 14(1):30-4. PubMed ID: 3514313
[TBL] [Abstract][Full Text] [Related]
11. [Piperacillin in the therapy of severe bacterial infections: comparison of its efficacy and tolerance vs. ceftazidime].
D'Amato C; Bordi E; De Carlo G; Puro V; Visco G
Clin Ter; 1989 Sep; 130(5):271-6. PubMed ID: 2530030
[TBL] [Abstract][Full Text] [Related]
12. Treatment of febrile episodes in neutropenic leukemic patients with the antibiotic combinations piperacillin or ceftazidime plus amikacin: results of a randomized study.
Fenu S; Raccah R; Santilli S; Micozzi A; Girmena C; Martino P; Avvisati G
Chemioterapia; 1988 Oct; 7(5):323-6. PubMed ID: 3066517
[TBL] [Abstract][Full Text] [Related]
13. A prospective, controlled, randomized, non-blind, comparative study of the efficacy and safety of a once daily high dose of ceftriaxone plus ciprofloxacin versus thrice daily ceftazidime plus amikacin in empirical therapy for febrile neutropenic patients.
Metallidis S; Kollaras P; Giannakakis T; Seitanidis B; Kordosis T; Nikolaidis J; Hatzitolios A; Nikolaidis P
Eur J Intern Med; 2008 Dec; 19(8):619-24. PubMed ID: 19046729
[TBL] [Abstract][Full Text] [Related]
14. [Infections in neutropenic children with neoplasms. Case series contribution].
Giacchino M; Artino RM; Miniero R; Grazia G; Vivalda M; Dotti G; Mattirolo F; Madon E
Minerva Pediatr; 1988 Jun; 40(6):339-44. PubMed ID: 3054471
[No Abstract] [Full Text] [Related]
15. [Clinical evaluation of monotherapy with ceftazidime for severe infections complicating hematological disorders. Hyogo Cooperative Study Group of Infectious Diseases Complicating Hematological Disorders].
Takemoto Y; Kanamaru A; Nagai K; Hara H; Nakayama S; Himei S; Ikeda T; Iwao N; Tago H; Yamaguchi N
Rinsho Ketsueki; 1989 Mar; 30(3):316-22. PubMed ID: 2671434
[TBL] [Abstract][Full Text] [Related]
16. [Efficacy of the combination of ceftazidime/vancomycin in the first line treatment of infection in neutropenic children].
Schaison G; Leverger G; Pappo M; Chiche D
Pathol Biol (Paris); 1990 Jun; 38(5 ( Pt 2)):557-60. PubMed ID: 2200996
[TBL] [Abstract][Full Text] [Related]
17. Should vancomycin be used empirically in febrile patients with prolonged and profound neutropenia? Results of a randomized trial.
Pico JL; Marie JP; Chiche D; Guiguet M; Andremont A; Lapierre V; Richet H; Tancrede C; Lagrange P; Hayat M
Eur J Med; 1993 May; 2(5):275-80. PubMed ID: 8252157
[TBL] [Abstract][Full Text] [Related]
18. Ceftazidime in pediatric infections unsuccessfully treated with other antibiotics: an evaluation of its efficacy and tolerability in compromised host.
Boner AL; Castellani C; Fostini R; Padovani E
Int J Clin Pharmacol Ther Toxicol; 1986 Jun; 24(6):333-6. PubMed ID: 2942496
[TBL] [Abstract][Full Text] [Related]
19. [Clinical results of the treatment of bacterial infections in children with ceftazidime].
Zoch-Zwierz W; Rudobielska M; Wierciński R; Winiecka W; Tomaszewska B
Pol Tyg Lek; 1989 Apr; 44(17):390-3. PubMed ID: 2696939
[TBL] [Abstract][Full Text] [Related]
20. Outpatient treatment of fever and neutropenia for low risk pediatric cancer patients.
Mullen CA; Petropoulos D; Roberts WM; Rytting M; Zipf T; Chan KW; Culbert SJ; Danielson M; Jeha SS; Kuttesch JF; Rolston KV
Cancer; 1999 Jul; 86(1):126-34. PubMed ID: 10391572
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
